Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (5)
- Lancaster LH, de Andrade JA, Zibrak JD, et al. Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev. 2017;26(146):170057. PubMed CrossRef
- Gupta M, Gupta V, Nagar Buckshee R, et al. Validity and reliability of Hindi translated version of Montreal cognitive assessment in older adults. Asian J Psychiatr. 2019;45:125–128. PubMed CrossRef
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. PubMed CrossRef
- Pinto C, Subramanyam AA. Mild cognitive impairment: the dilemma. Indian J Psychiatry. 2009;51 Suppl 1(Suppl1):S44–S51. PubMed
- Deng Z, Deng S, Zhang MR, et al. Fibroblast growth factors in depression. Front Pharmacol. 2019;10:60. PubMed CrossRef
Buy PDF for $40
Please sign in or purchase this PDF for $40.
Save
Share
Cite
